TXNDC8
gene geneOn this page
Also known as bA427L11.2TRX6SPTRX-3
Summary
TXNDC8 (thioredoxin domain containing 8, HGNC:31454) is a protein-coding gene on chromosome 9q31.3, encoding Thioredoxin domain-containing protein 8 (Q6A555). May be required for post-translational modifications of proteins required for acrosomal biogenesis.
Involved in spermatogenesis. Located in Golgi apparatus. Biomarker of male infertility.
Source: NCBI Gene 255220 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 19 total
- MANE Select transcript:
NM_001424031
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31454 |
| Approved symbol | TXNDC8 |
| Name | thioredoxin domain containing 8 |
| Location | 9q31.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA427L11.2, TRX6, SPTRX-3 |
| Ensembl gene | ENSG00000204193 |
| Ensembl biotype | protein_coding |
| OMIM | 617789 |
| Entrez | 255220 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000374507, ENST00000374510, ENST00000374511, ENST00000423740, ENST00000713575, ENST00000713585
RefSeq mRNA: 5 — MANE Select: NM_001424031
NM_001003936, NM_001286946, NM_001286947, NM_001364963, NM_001424031
CCDS: CCDS35104, CCDS69639, CCDS75872
Canonical transcript exons
ENST00000374511 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001463687 | 110337773 | 110337863 |
| ENSE00001463690 | 110303476 | 110303583 |
| ENSE00001463694 | 110329232 | 110329291 |
| ENSE00003238857 | 110326175 | 110326240 |
| ENSE00003334422 | 110334216 | 110334320 |
| ENSE00004020373 | 110304467 | 110304532 |
Expression profiles
Bgee: expression breadth broad, 48 present calls, max score 88.25.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0116 / max 12.1793, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 101924 | 0.0116 | 3 |
Top tissues by expression
183 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 88.25 | gold quality |
| right testis | UBERON:0004534 | 87.90 | gold quality |
| testis | UBERON:0000473 | 84.12 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 66.79 | gold quality |
| buccal mucosa cell | CL:0002336 | 64.26 | gold quality |
| endothelial cell | CL:0000115 | 57.19 | gold quality |
| upper leg skin | UBERON:0004262 | 52.58 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 51.16 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 45.71 | gold quality |
| endometrium | UBERON:0001295 | 45.63 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| lower lobe of lung | UBERON:0008949 | 40.34 | silver quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| mammary duct | UBERON:0001765 | 39.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.57 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- SPTRX3 is a novel Golgi apparatus-associated thioredoxin, and has a role in aberrant spermatogenesis (PMID:15181017)
- Data indicate that the elevated semen content of SPTRX3/TXNDC8 from assisted reproductive therapy (ART) couples coincided with reduced incidence of pregnancy by in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). (PMID:23734172)
- Sperm content of TXNDC8 reflects sperm chromatin structure, pregnancy establishment, and incidence of multiple births after ART. (PMID:32851881)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Txndc8 | ENSMUSG00000038709 |
| rattus_norvegicus | Txndc8 | ENSRNOG00000029073 |
| drosophila_melanogaster | CG14221 | FBGN0031042 |
Paralogs (4): TXNL1 (ENSG00000091164), TXN2 (ENSG00000100348), TXN (ENSG00000136810), TXNDC2 (ENSG00000168454)
Protein
Protein identifiers
Thioredoxin domain-containing protein 8 — Q6A555 (reviewed: Q6A555)
Alternative names: Spermatid-specific thioredoxin-3, Thioredoxin-6
All UniProt accessions (5): A0AAA9YHJ3, A0AAA9YHL0, A9Z1W9, B7ZME0, Q6A555
UniProt curated annotations — full annotation on UniProt →
Function. May be required for post-translational modifications of proteins required for acrosomal biogenesis. May act by reducing disulfide bonds within the sperm.
Subcellular location. Cytoplasm. Golgi apparatus.
Tissue specificity. Testis-specific. Only expressed during spermiogenesis, prominently in the Golgi apparatus of pachytene spermatocytes and round and elongated spermatids, with a transient localization in the developing acrosome of round spermatids (at protein level).
Miscellaneous. Increased levels, possibly caused by overexpression, are observed in morphologically abnormal spermatozoa from infertile men, suggesting that it may be used as a marker of aberrant spermatogenesis.
Similarity. Belongs to the thioredoxin family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6A555-1 | 1 | yes |
| Q6A555-2 | 2 |
RefSeq proteins (5): NP_001003936, NP_001273875, NP_001273876, NP_001351892, NP_001410960* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013766 | Thioredoxin_domain | Domain |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
Pfam: PF00085
UniProt features (5 total): chain 1, domain 1, disulfide bond 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6A555-F1 | 84.87 | 0.71 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 32–35
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 47 (showing top):
GOCC_SECRETORY_GRANULE, GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOCC_SECRETORY_VESICLE, GOCC_ACROSOMAL_VESICLE, GOMF_DISULFIDE_OXIDOREDUCTASE_ACTIVITY, MIKKELSEN_MEF_LCP_WITH_H3K27ME3, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, SUPT16H_TARGET_GENES, UBN1_TARGET_GENES, MIR3121_3P, MIR577, MIR3180_5P, MIR3182, MIR335_5P
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (5): acrosomal vesicle (GO:0001669), cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), extracellular exosome (GO:0070062), endomembrane system (GO:0012505)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| secretory granule | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| extracellular vesicle | 1 |
| vacuole | 1 |
| plasma membrane | 1 |
Protein interactions and networks
STRING
1772 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TXNDC8 | NME8 | Q8N427 | 530 |
| TXNDC8 | NME9 | Q86XW9 | 507 |
| TXNDC8 | CATSPERB | Q9H7T0 | 501 |
| TXNDC8 | SEPTIN12 | Q8IYM1 | 489 |
| TXNDC8 | DRC4 | O95995 | 453 |
| TXNDC8 | ENTPD6 | O75354 | 449 |
| TXNDC8 | GLRX | P35754 | 430 |
| TXNDC8 | EEPD1 | Q7L9B9 | 423 |
| TXNDC8 | CATSPERG | Q6ZRH7 | 420 |
| TXNDC8 | ODF1 | Q14990 | 402 |
| TXNDC8 | TEX53 | A0A1B0GU33 | 400 |
| TXNDC8 | TXNIP | Q9H3M7 | 387 |
| TXNDC8 | SPA17 | Q15506 | 383 |
| TXNDC8 | AADACL2 | Q6P093 | 375 |
| TXNDC8 | TXN2 | Q99757 | 374 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TXNDC8 | S100P | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (6): ANKRD13A (Affinity Capture-MS), POTEKP (Affinity Capture-MS), PCBP4 (Affinity Capture-MS), S100P (Affinity Capture-MS), TXNDC8 (Affinity Capture-MS), TXNDC8 (Affinity Capture-MS)
ESM2 similar proteins: C0HJG9, P08515, P09210, P09488, P15964, P18380, P27013, P27583, P35661, P46434, P46439, P48774, P49261, P50581, P51781, P68253, P68464, P68465, P82810, P83325, P85842, P86195, P86214, P86215, P86252, P86265, P86699, P93292, Q08863, Q10092, Q1ZXB9, Q5BG51, Q69AB2, Q6A555, Q6AXY0, Q7REH6, Q7RTV2, Q84TK0, Q8IWF7, Q96VH2
Diamond homologs: A2YIW7, D4B2L8, G4NFB7, O14463, O17486, O22022, O22779, O48897, O64394, O64654, O81332, O94504, O96952, O97508, O97680, P05307, P07237, P08628, P08629, P09856, P0AGG4, P0AGG5, P0AGG6, P0AGG7, P10599, P10639, P11232, P17967, P21609, P21610, P22217, P22803, P29448, P29449, P29450, P29451, P40557, P50413, P55059, P82460
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
773 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:110321572:A:C | donor_gain | 1.0000 |
| 9:110337430:T:TA | donor_gain | 1.0000 |
| 9:110333873:T:C | donor_gain | 0.9900 |
| 9:110334214:A:AC | donor_gain | 0.9900 |
| 9:110334215:C:CC | donor_gain | 0.9900 |
| 9:110337435:A:AC | donor_gain | 0.9900 |
| 9:110337436:C:CC | donor_gain | 0.9900 |
| 9:110337438:T:TA | donor_gain | 0.9900 |
| 9:110326168:AACAT:A | donor_loss | 0.9800 |
| 9:110326169:ACATA:A | donor_loss | 0.9800 |
| 9:110326170:CATAC:C | donor_loss | 0.9800 |
| 9:110326171:ATAC:A | donor_loss | 0.9800 |
| 9:110326172:TA:T | donor_loss | 0.9800 |
| 9:110326173:A:AT | donor_loss | 0.9800 |
| 9:110334207:TGTAC:T | donor_loss | 0.9800 |
| 9:110334208:GTAC:G | donor_loss | 0.9800 |
| 9:110334209:TAC:T | donor_loss | 0.9800 |
| 9:110334210:ACT:A | donor_loss | 0.9800 |
| 9:110334211:CTCAC:C | donor_loss | 0.9800 |
| 9:110334212:TCA:T | donor_loss | 0.9800 |
| 9:110334213:CACAT:C | donor_loss | 0.9800 |
| 9:110334214:A:T | donor_loss | 0.9800 |
| 9:110334215:C:CG | donor_loss | 0.9800 |
| 9:110334215:CAT:C | donor_gain | 0.9800 |
| 9:110334233:T:TA | donor_gain | 0.9800 |
| 9:110334317:CATT:C | acceptor_gain | 0.9800 |
| 9:110334319:TT:T | acceptor_gain | 0.9800 |
| 9:110334321:C:CC | acceptor_gain | 0.9800 |
| 9:110337435:ACTT:A | donor_gain | 0.9800 |
| 9:110337436:CTTC:C | donor_gain | 0.9800 |
AlphaMissense
857 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:110334264:A:C | F27L | 0.970 |
| 9:110334264:A:T | F27L | 0.970 |
| 9:110334266:A:G | F27L | 0.970 |
| 9:110326199:A:C | F77L | 0.938 |
| 9:110326199:A:T | F77L | 0.938 |
| 9:110326201:A:G | F77L | 0.938 |
| 9:110326190:G:C | F80L | 0.920 |
| 9:110326190:G:T | F80L | 0.920 |
| 9:110326192:A:G | F80L | 0.920 |
| 9:110329259:A:C | F54L | 0.913 |
| 9:110329259:A:T | F54L | 0.913 |
| 9:110329261:A:G | F54L | 0.913 |
| 9:110334265:A:G | F27S | 0.873 |
| 9:110334219:G:C | F42L | 0.870 |
| 9:110334219:G:T | F42L | 0.870 |
| 9:110334221:A:G | F42L | 0.870 |
| 9:110334271:A:T | V25D | 0.844 |
| 9:110329257:G:T | A55D | 0.822 |
| 9:110303572:A:C | F111L | 0.805 |
| 9:110303572:A:T | F111L | 0.805 |
| 9:110303574:A:G | F111L | 0.805 |
| 9:110334303:A:C | F14L | 0.804 |
| 9:110334303:A:T | F14L | 0.804 |
| 9:110334305:A:G | F14L | 0.804 |
| 9:110329258:C:G | A55P | 0.801 |
| 9:110334274:A:T | V24E | 0.796 |
| 9:110334265:A:C | F27C | 0.779 |
| 9:110326191:A:G | F80S | 0.773 |
| 9:110326200:A:G | F77S | 0.746 |
| 9:110334313:A:G | F11S | 0.742 |
dbSNP variants (sampled 300 via entrez): RS1000048448 (9:110300857 A>C), RS1000180351 (9:110318974 A>G), RS1000279504 (9:110307347 A>G), RS1000297334 (9:110337352 C>A,T), RS1000406783 (9:110313480 C>G), RS1000440093 (9:110309430 T>A,C), RS1000512528 (9:110320651 T>C), RS1000560077 (9:110320827 C>T), RS1000626020 (9:110312010 G>A), RS1000633740 (9:110323602 G>A,C), RS1000657148 (9:110312254 T>G), RS1000662225 (9:110324659 A>G), RS1000662307 (9:110303125 G>C), RS1000688951 (9:110325901 G>T), RS1000773536 (9:110317897 T>A,C)
Disease associations
OMIM: gene MIM:617789 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004865_42 | Itch intensity from mosquito bite adjusted by bite size | 3.000000e-07 |
| GCST008273_6 | Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma | 7.000000e-06 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008377 | mosquito bite reaction itch intensity measurement |
| EFO:0008378 | mosquito bite reaction size measurement |
| EFO:0004314 | forced expiratory volume |
| EFO:0007908 | traffic air pollution measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.